A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)

NCT07216482 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

975

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: Enlicitide
DRUG: Rosuvastatin
DRUG: Placebo for Enlicitide
DRUG: Placebo for Rosuvastatin

Sponsor

Merck Sharp & Dohme LLC